Director, Commercial, Switzerland

Das ist der Job

The company’s RD pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins.

Darum lohnt es sich

As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. /p h3Opportunity /h3 pThe Commercial Lead for Switzerland is responsible for defining and executing the local commercial strategy for the RevMEd portfolio and launches.

This role is accountable for building the commercial organization, driving launch and growth performance, and ensuring strong alignment across Medical Affairs, Market Access, and other key functions. /p pThe incumbent will proactively identify and address relevant systemic opportunities and barriers, including healthcare structures, competitor dynamics, data gaps, diagnostic challenges, and advocacy needs, as well as HCP-related opportunities such as therapeutic gaps, differentiation, economic value attributes, and clear communication of patient- and physician-relevant benefits. /p pThe Commercial Lead Switzerland will oversee the generation of insights from the therapeutic field and translate these insights into a comprehensive, cross-functional commercial strategy.

In support of clear positioning and an aligned communication approach, the incumbent will also ensure the development and implementation of tactics and tools that enable the field force to effectively address customer needs. /p h3Responsibilities /h3 ul liAct as the commercial lead for Switzerland, accountable for local commercial strategy, execution, and performance across the oncology portfolio. /li liServe as a core member of the Switzerland Leadership Team, contributing to country strategy, launch planning, and key business decisions. /li liPartner with regional and local Medical Affairs and Market Access teams to translate clinical and economic evidence into compelling value communications tailored to Swiss stakeholders, including HCPs and payers. /li liTranslate regional and global commercial strategies into locally optimized plans aligned with Swiss market dynamics, customer needs, and healthcare system requirements, in close collaboration with the European commercial team. /li liRepresent Switzerland in regional commercial discussions and contribute country insights to shape broader commercial plans and strategy. /li liDevelop and execute country-level brand and portfolio strategies across pre-launch, launch, and post-launch phases. /li liDrive demand generation and appropriate use through non-promotional and promotional channels, in compliance with local regulations. /li liLead forecasting, budgeting, and operational planning for the country in close collaboration with the ED, Commercial Excellence, Business Analytics and Insights, Europe. /li liLead commercial launch readiness for oncology products, including customer strategy, segmentation, targeting, and field force planning. /li liPartner closely with Medical Affairs and Market Access to ensure integrated launch execution and consistent external engagement. /li liMonitor performance, competitive dynamics, and market trends, adjusting strategy and execution as needed. /li liOversee engagement strategy across key stakeholders, including oncologists, treatment centers, and healthcare organizations. /li liEnsure effective field force deployment and capability building. /li liBuild, lead, and develop the country commercial organization, including sales, marketing, and customer-facing roles as the business scales. /li liEstablish commercial processes, governance, and ways of working as part of the country build-out. /li liFoster a culture of accountability, collaboration, and performance excellence. /li liContribute to regional and country-specific initiatives. /li liTravel nationally and internationally as required. /li /ul h3Required Skills, Experience and Education /h3 ul liAdvanced degree required, such as MSc, PhD, MD, or PharmD. /li li10+ years of experience in pharmaceutical or biotech commercial roles. /li liSignificant experience in oncology commercial leadership in Switzerland. /li liProven track record of successful oncology product launches in Switzerland and successful engagement with HCPs and KOLs. /li liExcellent communication skills, both in person and virtual. /li liScientific and solution-oriented mindset, with the ability to operate and execute effectively in a rapidly changing and ambiguous environment. /li liStrong understanding of the Swiss healthcare system, customer dynamics, and reimbursement environment. /li liProven leadership and people management capabilities, with demonstrated success in a small, fast-growing, entrepreneurial commercial environment. /li liHigh degree of social competence, with strong capabilities in teamwork, coaching, and situational leadership. /li /ul /p ppRevolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.

The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.